中文
EN
科研学术
Scientific Research
工作经历及教育背景 2022.07 至今 人工智能与数字经济广东省实验室（深圳）-智慧医疗团队副研究员
2019.04-2022.06 齐鲁工业大学（山东省科学院）-讲师
2015.08-2016.07 美国加州大学圣地亚哥分校-纳米工程系-交流访学
2013.09-2019.01 北京科技大学-化学专业-理学博士
2009.09-2013.06 海南大学-材料科学与工程专业-工学学士
代表性成果： 1. Su J, Sun C, Du J, Xing X, Wang F*, Dong H*. RNA-cleaving DNAzyme-based Amplification Strategies for Biosensing and Therapy. Adv. Healthcare Mater. 2023. DOI: 10.1002/adhm.202300367.
2. Jiao X, Wang Z, Wang F*, Wen Y*. Dual Stimuli-Responsive Controlled Release Nanocarrier for Multidrug Resistance Cancer Therapy. CHEMPHYSCHEM. 2019, 20, 3271-3275.
3. Wang F, Zhang L, Bai X, Cao X, Jiao X, Huang Y, Li Y, Qin Y*, Wen Y*. Stimuli Responsive Nano-Carrier for Co-delivery of MiR-31 and Doxorubicin to Suppress High MtEF4 Cancer. ACS Applied Materials & Interfaces. 2018, 10, 22767-22775.
4. Wang F, Wang Z, Li Y, Zhao L, Wen Y*, Zhang X. Cap-free pH/redox dual stimuli-responsive biodegradable nanocarrier for controlled drug release and chemo-photothermal combination therapy. Journal of Materials Chemistry B. 2018, 6, 8188-8195.
发表论文论著： 1. Su J, Sun C, Du J, Xing X, Wang F*, Dong H*. RNA-cleaving DNAzyme-based Amplification Strategies for Biosensing and Therapy. Adv. Healthcare Mater. 2023. DOI: 10.1002/adhm.202300367.
2. Jiao X, Wang Z, Wang F*, Wen Y*. Dual Stimuli-Responsive Controlled Release Nanocarrier for Multidrug Resistance Cancer Therapy. CHEMPHYSCHEM. 2019, 20, 3271-3275.
3. Wang F, Zhang L, Bai X, Cao X, Jiao X, Huang Y, Li Y, Qin Y*, Wen Y*. Stimuli Responsive Nano-Carrier for Co-delivery of MiR-31 and Doxorubicin to Suppress High MtEF4 Cancer. ACS Applied Materials & Interfaces. 2018, 10, 22767-22775.
4. Wang F, Wang Z, Li Y, Zhao L, Wen Y*, Zhang X. Cap-free pH/redox dual stimuli-responsive biodegradable nanocarrier for controlled drug release and chemo-photothermal combination therapy. Journal of Materials Chemistry B. 2018, 6, 8188-8195.
